Related Experiment Videos
Elevated serum and urine sialic acid levels in renal diseases
1Department of Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Annals of Clinical Biochemistry
|January 1, 1991
Summary
Total sialic acid (TSA) and lipid-associated sialic acid (LASA) levels are elevated in patients with chronic kidney disease (CKD) on dialysis. Despite increased serum levels, no correlation was found with kidney function markers like BUN or creatinine.
Area of Science:
- Biochemistry
- Nephrology
- Clinical Chemistry
Background:
- Chronic glomerulonephritis (CGN) and chronic renal failure (CRF) are significant health concerns.
- Sialic acids, particularly Total Sialic Acid (TSA) and Lipid-Associated Sialic Acid (LASA), are implicated in various physiological and pathological processes.
- Understanding sialic acid levels in renal disease is crucial for potential diagnostic or prognostic markers.
Purpose of the Study:
- To investigate Total Sialic Acid (TSA) and Lipid-Associated Sialic Acid (LASA) concentrations in patients with chronic glomerulonephritis (CGN) and chronic renal failure (CRF) undergoing haemodialysis.
- To establish reference values for TSA and LASA in healthy individuals.
- To explore correlations between TSA, LASA, and markers of renal function (BUN, creatinine).
Main Methods:
- Sera from 60 healthy subjects and patients with CGN/CRF on haemodialysis were analyzed for TSA and LASA.
- Reference values were determined in healthy controls, assessing age and sex dependency.
- Statistical analysis was performed to evaluate correlations between sialic acid levels and serum BUN/creatinine.
Main Results:
- Significantly elevated serum TSA and LASA concentrations were observed in patients with CGN and CRF on haemodialysis compared to healthy controls.
- Reference values for TSA and LASA in healthy subjects showed no significant dependence on age or sex.
- No significant correlation was found between TSA and LASA values, nor between these markers and serum BUN or creatinine levels in either patient or control groups.
- Increased excretion of bound sialic acids in the urine was noted in both patient groups despite elevated serum levels.
Conclusions:
- Serum TSA and LASA are elevated in patients with CGN and CRF undergoing haemodialysis.
- These elevated sialic acid levels do not correlate with standard markers of renal function (BUN, creatinine) in these patients.
- The findings suggest that while sialic acids may be altered in advanced renal disease, their direct correlation with kidney function markers needs further investigation, and urinary excretion patterns warrant additional study.